| Literature DB >> 34616162 |
Tesfaye Belachew1, Eyuel Mulusew2, Yonas Tolosa2, Zerihun Asefa3, Haileleul Negussie4, Teshale Sori4.
Abstract
PURPOSE: Salmonellosis is a foodborne zoonoses found worldwide. The main purpose of this study was to isolate and identify Salmonella and assess their antimicrobial susceptibility profiles from smallhold broilers supply chains and slaughterhouses in Bishoftu and Modjo, central Ethiopia.Entities:
Keywords: Salmonella; antimicrobials; broilers; central Ethiopia; resistance; smallhold farms
Year: 2021 PMID: 34616162 PMCID: PMC8487853 DOI: 10.2147/IDR.S331249
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Figure 1Map of Ethiopia depicting the study areas.
Antimicrobials used for assessment of sensitivity profiles of Salmonella isolates and classification of sensitivity patterns
| Resistance (mm) | Intermediate (mm) | Susceptible (mm) | |
|---|---|---|---|
| Gentamicin (10 μg) | ≤12 | 12–15 | ≥15 |
| Erythromycin (15 μg) | ≤13 | 13–18 | ≥18 |
| Streptomycin (10 μg) | ≤11 | 11–15 | ≥15 |
| Chloramphenicol (30 μg) | ≤12 | 12–18 | ≥18 |
| Sulfamethazole–trimethoprim (25 μg) | ≤10 | 10–16 | ≥16 |
| Tetracycline (10 μg) | ≤14 | 14–19 | ≥19 |
| Ampicillin (10 μg) | ≤13 | 13–17 | ≥17 |
| Cloxaciline (5 μg) | ≤10 | 11–12 | ≥13 |
| Naldixic acid (30 μg) | ≤13 | 14–18 | ≥19 |
| Amoxicillin (25 μg) | 14–17 | ≥17 | |
| Kanamycin (30 μg) | ≤13 | 14–17 | ≥18 |
Prevalence of Salmonella isolated from each sample collected from selected study farms
| Sample type | Tested, n | Prevalence | 95% CI | |
|---|---|---|---|---|
| Cloacal swab | 189 | 50 | 26.46% | 20.32%–33.35% |
| Cecum content | 100 | 21 | 21.00% | 13.49%–30.29% |
| Feed | 52 | 16 | 30.77% | 18.72%–45.10% |
| Water | 48 | 12 | 25.00% | 13.64%–39.59% |
| Water trough | 60 | 12 | 20.00% | 10.78%–32.33% |
| Feed trough | 90 | 20 | 22.22% | 14.13%–32.21% |
| B1 | 125 | 24 | 19.20% | 12.71%–27.21% |
| B2 | 125 | 31 | 24.80% | 17.51%–33.32% |
| M1 | 144 | 39 | 27.08% | 20.02%–35.11% |
| M2 | 145 | 37 | 25.52% | 18.65%–33.42% |
| Total | 539 | 131 | 24.30% | 20.74%–28.15% |
Proportion of samples yielding positive results for Salmonella by risk factor
| Tested, n | Prevalence | OR | 95% CI | ||||
|---|---|---|---|---|---|---|---|
| Age (days) | 21–30 | 95 | 19 | 20.00% | 0.565 | 0.14–3.33 | 0.429 |
| 31–40 | 144 | 41 | 28.47% | ||||
| 41–45 | 50 | 11 | 22.00% | ||||
| Breed | Ross 308 | 75 | 10 | 13.33% | 0.903 | 0.24–3.48 | 0.881 |
| Hubbard classic | 144 | 41 | 28.47% | ||||
| Cobb 500 | 70 | 20 | 28.57% | ||||
| Source of water | Tap | 146 | 32 | 21.92% | 1.472 | 0.65–3.39 | 0.358 |
| Tank | 143 | 39 | 27.27% | ||||
| Type of house | Hoop | 194 | 45 | 23.20% | 0.375 | 0.03–3.84 | 0.412 |
| Cement block | 95 | 26 | 27.37% | ||||
| Farm location | Residential compound | 145 | 41 | 28.28% | 0.650 | 0.23–0.39 | 0.264 |
| Separate | 144 | 30 | 20.83% | ||||
| Type of sample | Cloacal swab | 189 | 50 | 26.46% | 3.268 | 0.41–29.10 | 0.272 |
| Cecum content | 100 | 21 | 21.00% | ||||
| Feed | 52 | 16 | 30.77% | ||||
| Water | 48 | 12 | 25.00% |
Antimicrobial-sensitivity profiles of Salmonella isolated
| Resistance (%) | Intermediate (%) | Susceptible (%) | |
|---|---|---|---|
| Gentamicin (10 μg) | 10 (10.10) | 20 (20.20) | 69 (69.70) |
| Erythromycin (15 μg) | 24 (24.24) | 35 (35.35) | 40 (40.41) |
| Streptomycin (10 μg) | 59 (59.60) | 24 (24.24) | 16 (16.16) |
| Chloramphenicol (30 μg) | 67 (67.68) | 17 (17.17) | 15 (15.15) |
| Sulfamethazole–trimethoprim (25 μg) | 61 (61.62) | 22 (22.22) | 16 (16.16) |
| Tetracycline (10 μg) | 80 (80.81) | 16 (16.16) | 3 (3.03) |
| Ampicillin (10 μg) | 54 (54.55) | 23 (23.23) | 22 (22.22) |
| Cloxacilline (5 μg) | 29 (29.29) | 27 (27.27) | 43 (43.44) |
| Naldixic acid (30 μg) | 63 (63.64) | 23 (23.23) | 13 (13.13) |
| Amoxicillin (25 μg) | 67 (67.68) | 19 (19.19) | 13 (13.13) |
| Kanamycin (30 μg) | 71 (71.72) | 18 (18.18) | 10 (18.18) |